We report the first structural determination of the metastable β polymorph of nifedipine (NIF) by single-crystal X-ray diffraction. Stable, high-quality crystals were grown from the melt in the presence of a polymer dopant. Our β NIF structure is characterized by a unit cell similar to that of the structure recently proposed from powder diffraction, but significantly different molecular conformations. Unlike the stable α polymorph, β NIF undergoes a reversible solid-state transformation near 60 °C. The now available β NIF structure clarifies some confusion concerning NIF polymorphs and enables inquiries into the structural basis for the selective crystallization of β NIF from glasses. We report that another polymorph crystallizes concomitan...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
The amorphous → metastable and metastable → stable crystalline phase transitions of nifedipine and t...
Purpose. To examine the thermal transition(s) between different polymorphic forms of Nifedipine and ...
In this study the polymorphs of tolbutamide, an oral hypoglicemiant used on Diabetes Mellitus type I...
Any time the pharmaceutical industry develops a new drug, potential polymorphic events must be thoro...
Any time the pharmaceutical industry develops a new drug, potential polymorphic events must be thoro...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, MA, has been known to ex...
Controlling the shape of crystals is of great practical relevance in pharmaceutical manufacturing. I...
(±)-Modafinil is an active pharmaceutical ingredient that crystallizes in several polymorphic forms....
Polymorphism, the ability of a substance to crystallize in two or more different structures, is a fu...
(±)-Modafinil is an active pharmaceutical ingredient that crystallizes in several polymorphic forms....
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
The amorphous → metastable and metastable → stable crystalline phase transitions of nifedipine and t...
Purpose. To examine the thermal transition(s) between different polymorphic forms of Nifedipine and ...
In this study the polymorphs of tolbutamide, an oral hypoglicemiant used on Diabetes Mellitus type I...
Any time the pharmaceutical industry develops a new drug, potential polymorphic events must be thoro...
Any time the pharmaceutical industry develops a new drug, potential polymorphic events must be thoro...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, MA, has been known to ex...
Controlling the shape of crystals is of great practical relevance in pharmaceutical manufacturing. I...
(±)-Modafinil is an active pharmaceutical ingredient that crystallizes in several polymorphic forms....
Polymorphism, the ability of a substance to crystallize in two or more different structures, is a fu...
(±)-Modafinil is an active pharmaceutical ingredient that crystallizes in several polymorphic forms....
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...
Two previously known polymorphs (forms I and II) and two new polymorphs (forms III and IV) of the ca...